分子研究和尿道癌的治疗
1Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
International journal of molecular sciences
|January 8, 2025
概括
泌尿系统癌症显示出显著的瘤异质性,影响治疗反应. 了解这些不同特征对于开发有效的癌症疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 癌症生物学 癌症生物学
背景情况:
- 泌尿系统癌症,包括膀,前列腺和癌,表现出相当大的异质性.
- 瘤异质性表现在形态,基因表达和表型特征上.
- 这种异质性有助于对治疗干预的不同反应.
研究的目的:
- 探索尿道恶性瘤中瘤异质性的多面性.
- 调查异质性对药物治疗疗效的影响.
- 确定潜在的治疗策略,以解释瘤多样性的原因.
主要方法:
- 审查有关尿道癌异质性的现有文献.
- 对基因表达特征和表型数据的分析.
- 对不同瘤亚型的治疗结果进行比较研究.
主要成果:
- 在尿道瘤中证实了细胞形态和遗传构成的显著变异.
- 证明了特定异质特征和差异性药物敏感性之间的直接相关性.
- 确定了与治疗耐药性相关的独特分子亚型.
结论:
- 瘤异质性是尿道癌治疗结果的关键决定因素.
- 根据个体瘤特征量身定制治疗方法对于改善患者预后至关重要.
- 对特定尿道癌亚型的向疗法进行进一步的研究是有必要的.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


